The implication that cancer cell metabolism may be driven by a tumour specific PKM2 raised the prospect of an attractive therapeutic target but then further work indicated that PKM2 was also the predominant isoform present in matched normal tissue [94] as had indeed been observed many years earlier [95]. This evidence concerns the gene PKM and cancer.